| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | 961YV2O515 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | IgG receptor FcRn large subunit p51 antagonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pemphigoid, Bullous | 3 | D010391 | ClinicalTrials |
| Thrombocytopenia | 3 | D013921 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic | 3 | D016553 | ClinicalTrials |
| Graves Ophthalmopathy | 3 | D049970 | ClinicalTrials |
| Sjogren's Syndrome | 2 | D012859 | ClinicalTrials |
| Lupus Nephritis | 2 | D008181 | ClinicalTrials |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 | D020277 | ClinicalTrials |
| Kidney Diseases | 2 | D007674 | ClinicalTrials |
| Guillain-Barre Syndrome | 2 | D020275 | ClinicalTrials |
| Orthostatic Intolerance | 2 | D054971 | ClinicalTrials |
| Optic Neuritis | 2 | D009902 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297551 |
| FDA SRS | 961YV2O515 |
CONTENTS